Three Things we Learned in our 2026 Preview Webinar
Obesity. China. FDA turmoil. Our pharma 2026 Preview webinar was not the place to look for a change in the big pharma buzzwords for this year. These big themes remain with us for now. But there was still plenty for our expert panel to discuss during the session. If you missed it, you can catch […]
2024 Dealmaking: What’s the Score?
Volume is up but value is down. That’s the headline of the dealmaking scene for the first half of 2024. There’s not been a mega-merger in the vein of 2023’s Pfizer/Seagen deal, though the Novo/Catalent deal aimed at boosting supplies of the semaglutide products Ozempic and Wegovy is certainly notable. Even so, the 18% increase […]
In Case You Missed It: Three Things we Learned in our AI Forecasting Webinar
If you missed our recent webinar, AI and ML in Pharma: Redefining the Forecasting Landscape, then I hope it’s because you were on a lovely vacation somewhere. Now that you’re back, though, you’ll be delighted to know that it’s available on demand so you can catch up at your leisure. Our panel, which included Daniel […]
Unlocking the Power of AI in Pharmaceutical Forecasting
There is no shortage of discussion about the opportunities presented by artificial intelligence and AI in the pharma industry. 50% of global healthcare companies plan to implement AI strategies by next year and AI’s impact on new drug development is expected to grow 40% annually. There is no part of the pharmaceutical ecosystem that isn’t […]
The Future of Pharma Forecasting
What is FC365? In the fast-paced and ever-evolving world of pharmaceutical forecasting, having access to modern, high-performing tools is crucial. FC365 is addressing the industry’s unique needs, empowering forecasting teams to work more effectively and efficiently. Implementation of this SaaS platform across many leading pharma is now streamlining processes and bringing efficiencies. Saving teams valuable […]
Knowledge and Insights: The Power of Real-World Data
Buzzwords in the life sciences industry – there are many: Artificial Intelligence (AI), Gen AI, Machine Learning (ML), digital health, and real-world data (RWD)/real world evidence (RWE). All are vast, complex areas with notable potential to impact our clients and the industry overall – across the continuum of the product lifecycle, spanning clinical and commercial […]
Evaluate Omnium: An Award-Winning Decision
Evaluate Omnium is now officially an award-winning solution! Last month, we were delighted to announce that we have won an award. Evaluate Omnium, our machine learning-powered solution was named as Best Decision Management Solution by the AI Breakthrough awards. While we have always been very proud of Evaluate Omnium, and while we know that […]
Machine Learning and Intelligent Forecasting: Beyond the Black Box
The black box. That mysterious widget in which myriad magic tricks reside. For some it is a magical force that delivers exactly what you need, even if you don’t entirely understand how. For others, it is at best untrustworthy and at worst, dangerous. And any solution that offers machine learning, artificial intelligence or predictive analytics […]
What is Intelligent Forecasting?
Intelligent forecasting is a hugely powerful tool for the life sciences industry…but what exactly IS it? These days we are not short on buzzwords around artificial intelligence. While experts can wax lyrical about the differences between AI, machine learning, and natural language processing, mere mortals are often left scratching their heads. For many people, it’s […]
Demystifying AI: Natural Language Processing (Part Two)
Natural language processing (NLP) is a key component of many machine learning approaches. We’ve looked at (broadly) how it works, now we investigate some of they key use cases in the life sciences industry. In the first part of this blog post, we looked at how Natural Language Processing works (at a high level, of […]
